Standout Papers

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with... 2015 2026 2018 2022 580
  1. Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma (2015)
    Christine E. Brown, Behnam Badie et al. Clinical Cancer Research

Immediate Impact

6 by Nobel laureates 31 from Science/Nature 73 standout
Sub-graph 1 of 18

Citing Papers

De novo design of allosterically switchable protein assemblies
2024 StandoutNatureNobel
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
2022 StandoutNature
1 intermediate paper

Works of Massimo D’Apuzzo being referenced

Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
2017
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
2015 Standout

Author Peers

Author Last Decade Papers Cites
Massimo D’Apuzzo 1773 1212 548 735 67 3.2k
Brian Rabinovich 1581 1708 239 1068 45 3.2k
Frances T. Hakim 2089 2883 430 1134 82 5.6k
Irina Marić 3306 2187 1089 1717 124 6.1k
Genevieve M. Boland 2238 1362 650 2076 114 5.4k
Nabil Ahmed 4032 1733 558 1285 84 5.6k
Jiang F. Zhong 905 434 185 1073 88 2.3k
Saba Ghassemi 2174 1243 80 1216 40 3.7k
Linda M. Pilarski 1209 1215 584 2895 170 5.5k
Marc Schmitz 2775 3156 821 2003 171 6.2k
Nicole M. Haynes 2267 2540 78 1054 57 4.1k

All Works

Loading papers...

Rankless by CCL
2026